ORG Partners’s AbbVie ABBV Stock Holding History

ORG Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.34M	Buy	5,857 +417	+8%	+$95K	0.24%	94
2025 Q3	$1.26M	Sell	5,440 -401	-7%	-$81.7K	0.23%	94
2025 Q2	$1.02M	Buy	5,841 +1,776	+44%	+$330K	0.22%	96
2025 Q1	$761K	Sell	4,065 -8,031	-66%	-$1.56M	0.19%	99
2024 Q4	$2.16M	Buy	12,096 +2,535	+27%	+$466K	0.29%	61
2024 Q3	$1.89M	Sell	9,561 -12,515	-57%	-$2.34M	0.3%	61
2024 Q2	$3.76M	Buy	22,076 +20,654	+1,452%	+$3.42M	0.47%	45
2024 Q1	$257K	Sell	1,422 -27,402	-95%	-$4.72M	0.49%	34
2023 Q4	$4.47M	Buy	28,824 +7,525	+35%	+$1.1M	0.75%	34
2023 Q3	$3.18M	Sell	21,299 -1,080	-5%	-$159K	0.94%	18
2023 Q2	$3.02M	Sell	22,379 -5,111	-19%	-$749K	0.49%	44
2023 Q1	$4.39M	Buy	+27,490	New	+$4.2M	1.07%	25

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ORG Partners's ABBV Position: Q4 2025 in Review

ORG Partners increased its AbbVie (ABBV) stake by 7.7% in Q4 2025, buying an estimated $95K and bringing the position to 5,857 shares worth $1.34M. The position accounts for 0.24% of the portfolio, ranked #94.

ORG Partners first reported a position in ABBV in Q1 2023 and has held it in 12 quarters since. The position peaked at $4.47M in Q4 2023. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

ORG Partners held 5,857 shares of AbbVie worth $1.34M as of Q4 2025.
ORG Partners bought 417 AbbVie shares in Q4 2025, an estimated $95K.
AbbVie made up 0.24% of ORG Partners's portfolio in Q4 2025, its #94 holding.
ORG Partners first reported a position in AbbVie in Q1 2023 and has held it in 12 quarters since.
ORG Partners's AbbVie position peaked at $4.47M in Q4 2023.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.